View Author
patient troponin level mortality trial abciximab study syndrome heart treatment troponin t 30 days infarction -15 result group elevation death stent gdf -15 levels gdf -15 1- year mortality baseline angina disease outcome artery disease nt-probnp artery marker quartile revascularisation circulation dalteparin assay value cohort event follow-up st 2 levels /iiia table placebo randomized gusto cardiology troponin i troponin i assay professor gusto-iv nste-ac relation analysis st-segment 1 year gusto iv-acs analyses randomization prognostic revascularization 72 hours heart failure therapy inhibitor 0.001 platelet difference effect infusion investigator intervention c-reactive protein signi protein ͻ0.001 stent thrombosis depression university figure creatinine
10 Most Recent Publications
|
Photofeature: European cardiovascular researchers on holiday and outside of work
(Article)
Heptinstall, S. Spaulding, C.M. Danser, A.H.J. Halvorsen, S. James, S.K. Tuomilehto, J. Hohnloser, S.H. Lefèvre, T. Carmeliet, P. Gittenberger-De Groot, A.C. |
2010-08-17
|
|
ST2 and mortality in non-ST-segment elevation acute coronary syndrome
(Article)
Eggers, K.M. Armstrong, P.W. Califf, R.M. Simoons, M.L. Venge, P. Wallentin, L.C. James, S.K. |
2010-05-01
|
|
Meeting report: ESC forum on drug eluting stents European heart house, Nice, 27-28 September 2007
(Article)
Daemen, J. Simoons, M.L. Fajadet, J. Gitt, A.K. Guagliumi, G. Hillege, H.L. James, S.K. Jùni, P. Kastrati, A. Kloth, S. Kristensen, S.D. Krucoff, M. Wijns, W. Legrand, V.M.G. Pfisterer, M.E. Rothman, M. Serruys, P.W.J.C. Silber, S. Steg, P.G. Tariah, I. Wallentin, L.C. Windecker, S. Aimonetti, A. Bagust, A. Allocco, D. Baczynska, A. Berenger, M. Boam, A. Calle, J.P. Campo, G. Carlier, S.G. Schepper, J. de Bisceglie, G. di Dobbels, H. Bos, G. Farb, A. Ghislain, J.C. Hellbardt, S. Hoedt, R. ten Isaia, C. Jong, P. de Klasen, E. Lekehal, M. LeNarz, L. Ni Mhullain, F. Bowen, J.M. Nagai, H. Patteet, A. Paunovic, D. Potgieter, A. Purdy, I. Raveau-Landon, C. Ternstrom, S. Wuytswinkel, J. van Waliszewski, M. Braunwald, E. Camenzind, E. Chevalier, B. DiMario, C. |
2009-01-01
|
|
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
(Article)
Wollert, K.C. Kempf, T. Armstrong, P.W. Califf, R.M. Drexler, H. Wallentin, L.C. Peter, T. Olofsson, S. James, S.K. Johnston, N. Lindahl, B. Horn-Wichmann, R. Brabant, G. Simoons, M.L. |
2007-02-01
|
|
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.
(Article)
Ottervanger, J.P. Barnathan, E.S. Boersma, H. Cooper, J.S. Ohman, E.M. James, S.K. Wallentin, L.C. Simoons, M.L. Armstrong, P.W. |
2004-09-01
|
|
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
(Article)
James, S.K. Lindahl, B. Califf, R.M. Simoons, M.L. Venge, P. Wallentin, L.C. Armstrong, P.W. |
2004-02-01
|
|
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: A GUSTO IV substudy
(Article)
James, S.K. Siegbahn, A. Califf, R.M. Simoons, M.L. Wallentin, L.C. Armstrong, P.W. Barnathan, E.S. |
2004-02-01
|
|
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO IV trial
(Article)
James, S.K. Califf, R.M. Simoons, M.L. Venge, P. Wallentin, L.C. Lindahl, B. Armstrong, P.W. |
2003-08-15
|
|
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
(Article)
James, S.K. Lindahl, B. Armstrong, P.W. Siegbahn, A. Stridsberg, M. Venge, P. Barnathan, E.S. Califf, R.M. Topol, E.J. Simoons, M.L. Wallentin, L.C. |
2003-07-22
|
|
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. A GUSTO IV substudy
(Article)
James, S.K. Barnathan, E.S. Califf, R.M. Lindahl, B. Siegbahn, A. Simoons, M.L. Topol, E.J. Venge, P. Wallentin, L.C. Armstrong, P.W. |
2003-03-19
|
